Corporate Partnerships of the American Kidney Fund for 2025

Unveiling the 2025 Corporate Members of the American Kidney Fund
Today marks an important milestone for the American Kidney Fund (AKF). This year, they proudly announce their 2025 Class of Corporate Members. These esteemed partners play a critical role in AKF’s efforts to combat kidney disease and provide invaluable support to those affected. Corporate Members are key to AKF’s mission, both financially and through collaboration.
LaVarne A. Burton, the President and CEO of AKF, expressed gratitude towards both returning and new Corporate Members. According to her, their support enables AKF to expand resources and enhance programming, ultimately benefiting the kidney patient community. Without these partnerships, the fight against kidney disease would be significantly hindered.
Meet the 2025 Class of Corporate Members
The 2025 Corporate Members reflect a commitment to the kidney health mission:
Champion Level
- Novartis Pharmaceutical Corporation
- Travere Therapeutics, Inc.
Patron Level
- Amgen, Inc.
- Boehringer Ingelheim
- Novo Nordisk A/S
- Spherix Global Insights
- Vertex Pharmaceuticals, Inc.
Advocate Level
- Akebia Therapeutics, Inc.
- Alexion Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals, Inc.
- Ardelyx, Inc.
- argenx SE
- AstraZeneca plc
- CSL Vifor
- Otsuka America Pharmaceutical, Inc.
- Pfizer Inc.
- Pharmaceutical Research and Manufacturers of America (PhRMA)
- Sanofi
Friend Level
- ANI Pharmaceuticals, Inc.
- Apellis Pharmaceuticals, Inc.
- Bayer U.S. LLC
- Bristol Myers Squibb
- Hansa BioPharma AB
- Merck & Co.
- Natera
- Vera Therapeutics, Inc.
Impact of Corporate Membership
The Corporate Members are essential to AKF’s ability to maximize its impact on kidney disease. An impressive 97 cents of every dollar donated goes directly into programs and initiatives that aid those affected by kidney disease. This commitment to stewardship has earned AKF 24 consecutive 4-star ratings from Charity Navigator, making it a trusted resource in the nonprofit sector.
The resources provided by the Corporate Members fund vital programs that include award-winning kidney health education, advocacy for policy improvements, and groundbreaking clinical research. AKF's programs reach millions, directly enhancing the lives of individuals dealing with kidney disease.
The Importance of Partnerships
The AKF Corporate Membership Program remains open to organizations that align with their mission. By engaging in partnership with AKF, businesses can contribute to the fight against kidney disease and enhance the quality of life for millions. The collaboration aims to not only provide immediate support but also inspire long-term solutions for kidney health.
For those interested in becoming part of this mission, they can reach out to Daniel Green, the corporate engagement manager, for further details through the AKF.
About the American Kidney Fund
The American Kidney Fund is a leading nonprofit dedicated to improving the lives of those affected by kidney disease. With a focus on prevention, management, and advocacy, AKF addresses issues from early detection to post-transplant care. They are deeply invested in the well-being of the community, ensuring that programs effectively serve those who need assistance. AKF continues to be one of the top-rated nonprofits, focusing the majority of donations directly on beneficial programs.
This ensures that not only are people receiving assistance but that the fight against kidney disease is comprehensive and impactful.
Frequently Asked Questions
What is the main role of AKF's Corporate Members?
Corporate Members support AKF by financing essential programs and initiatives aimed at combating kidney disease.
How does AKF ensure the effective use of donations?
AKF consistently allocates 97 cents of every dollar to programs that directly benefit those affected by kidney disease.
What types of organizations can become Corporate Members?
Any institutional partner that supports AKF’s mission is encouraged to join as a Corporate Member.
What programs are funded through Corporate Membership?
A variety of programs, including education, advocacy, and clinical research, are funded through Corporate Membership.
How can I get more information about AKF?
To learn more about AKF and its services, visit their official website or contact their corporate engagement manager.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.